| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |